Early dosing practices and effectiveness of recombinant human erythropoietin
Open Access
- 1 May 1993
- journal article
- Published by Elsevier in Kidney International
- Vol. 43 (5) , 1125-1133
- https://doi.org/10.1038/ki.1993.158
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Biotechnology — The Enormous Cost of SuccessNew England Journal of Medicine, 1991
- ErythropoietinNew England Journal of Medicine, 1991
- Recombinant Human Erythropoietin and Renal Anemia: Molecular Biology, Clinical Efficacy, and Nervous System EffectsAnnals of Internal Medicine, 1991
- Recombinant Erythropoietin Improves Exercise Capacity in Anemic Hemodialysis PatientsAmerican Journal of Kidney Diseases, 1990
- Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.BMJ, 1990
- The Quality of Life of Hemodialysis Recipients Treated With Recombinant Human ErythropoietinJAMA, 1990
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Acquisition and Application of New Medical Knowledge by AnesthesiologistsAnesthesiology, 1978